Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Fate Therapeutics (NQ: FATE )

89.75 USD +1.33 (+1.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 11, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,070,423
Open 88.05
Bid (Size) 73.00 (4)
Ask (Size) 90.25 (1)
Prev. Close 88.42
Today's Range 86.47 - 90.99
52wk Range 29.30 - 121.16
Shares Outstanding 94,035,763
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Fate Therapeutics Highlights Positive Interim Data from its Phase 1 Study of FT516 in Combination with Rituximab for B-cell Lymphoma at 2021 ASCO Annual Meeting
From GlobeNewswire News Releases
Fate Therapeutics to Present at Upcoming Investor Conferences
From GlobeNewswire News Releases

Performance

YTD
+0.08%
+0.08%
1 Month
+24.15%
+24.15%
3 Month
-4.51%
-4.51%
6 Month
-5.27%
-5.27%
1 Year
+200.67%
+200.67%

More News

Read More
Fate Therapeutics Announces Encouraging Interim Phase 1 Data for iPSC-derived NK Cell Programs in Relapsed / Refractory Acute Myeloid Leukemia
From GlobeNewswire News Releases
Fate Therapeutics Stock is Trading Higher on Positive B-Cell Lymphoma Data at ASCO21
Tags Briefs News Market News
From Benzinga
FATE Crosses Above Key Moving Average Level
Tags Stocks
From Market News Video
Add Up The Parts: MOON Could Be Worth $46
Tags ETFs
From ETF Channel
Fate Therapeutics' iPSC-Derived Cell Therapies Induce Leukemic Blast Clearance, Show Durable Remissions In AML Patients
Tags News Briefs myeloid leukemia
From Benzinga
Fate Therapeutics Breaks Below 200-Day Moving Average - Notable for FATE
Tags Stocks
From Market News Video
The Best Biotech Stocks to Buy With $500
Tags IONS BIIB FATE
From Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags SNES KMPH BZI/TFM
From Benzinga
Stocks Showing Rising Market Leadership: Fate Therapeutics Earns 81 RS Rating
From Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.